Kythera Biopharmaceuticals, Inc.
Q2 2015 13F Holders
Symbol
KYTH
CUSIP
501570105
Type
Equity
Class
COM
Num filings
174
Total reported value, excl. options
$1.67 B
Compare 2015 Q2 to
2015 Q3
2015 Q1
2014 Q4
2014 Q3
2014 Q2
2014 Q1
Manager
Report Date
Value ($000)
Shares
Option Type